{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T06:19:03Z","timestamp":1792304343631,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1136\/ijgc-00009577-200807000-00033","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T05:16:25Z","timestamp":1729487785000},"page":"820-824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Is adjuvant therapy necessary for Stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging?"],"prefix":"10.1016","volume":"18","author":[{"given":"J.S.","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00000478-198203000-00002","article-title":"Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma","volume":"6","author":"Hendrickson","year":"1982","journal-title":"Am J Surg Pathol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/gyno.2001.6159","article-title":"Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I\u2013III) disease","volume":"81","author":"Bristow","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0090-8258(03)00195-1","article-title":"Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium","volume":"90","author":"Chan","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0020","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0090-8258(87)90278-2","article-title":"Therapeutic approaches to uterine papillary serous carcinoma: a preliminary report","volume":"26","author":"Christman","year":"1987","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0025","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/gyno.1994.1208","article-title":"Uterine papillary serous carcinoma: patterns of metastatic spread","volume":"54","author":"Goff","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0030","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/00006250-198605000-00013","article-title":"Papillary serous adenocarcinoma of the endometrium","volume":"67","author":"Jeffrey","year":"1986","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0035","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ygyno.2003.08.018","article-title":"Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases","volume":"91","author":"Slomovitz","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1525-1438.1992.02010009.x","article-title":"Carcinoma of the endometrium in Norway: a histopathological and prognostic survey of a total population","volume":"2","author":"Abeler","year":"1992","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0045","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0090-8258(03)00199-9","article-title":"Improved outcome at 10 years for serous-papillary\/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation","volume":"90","author":"Martinez","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/gyno.1993.1006","article-title":"A new aggressive treatment approach to high-grade endometrial cancer of possible benefit to patients with Stage I uterine papillary cancer","volume":"48","author":"Rosenberg","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0360-3016(97)00581-6","article-title":"Effective treatment of Stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy","volume":"40","author":"Turner","year":"1998","journal-title":"Int J Radiat OncolBiol Phys"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0060","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/1097-0142(19911001)68:7<1516::AID-CNCR2820680709>3.0.CO;2-X","article-title":"Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinoma","volume":"68","author":"Frank","year":"1991","journal-title":"Cancer"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0065","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2005.06.012","article-title":"Improved survival in surgical Stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy","volume":"98","author":"Kelly","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0070","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.ijrobp.2004.01.044","article-title":"The role of abdominal-pelvic radiotherapy in the management of uterine papillary serous carcinoma","volume":"59","author":"Kwon","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0075","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/1097-0142(20010215)91:4<752::AID-CNCR1061>3.0.CO;2-E","article-title":"Early stage uterine papillary serous carcinoma of the endometrium: effect of adjuvant whole abdominal radiotherapy and pathologic parameters on outcome","volume":"91","author":"Lim","year":"2001","journal-title":"Cancer"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/gyno.1998.5147","article-title":"Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO Stage 1a and 1b endometrial adenocarcinoma: treatment implications","volume":"71","author":"Aquino-Parsons","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0085","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/gyno.2000.5746","article-title":"Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker cancer centre between 1984 and 1994","volume":"77","author":"Craighead","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0090","first-page":"153","article-title":"Noninvasive papillary serous carcinoma of the endometrium","volume":"97","author":"Gehrig","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/gyno.1998.4956","article-title":"Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients","volume":"69","author":"Grice","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0100","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ygyno.2007.01.041","article-title":"Outcomes in surgical Stage I uterine papillary serous carcinoma","volume":"105","author":"Havrilesky","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0105","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijrobp.2006.08.006","article-title":"Adjuvant paclitaxel and carboplatin chemotherapy with involved field radiation in advanced endometrial cancer: a sequential approach","volume":"67","author":"Lupe","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0110","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ygyno.2003.09.025","article-title":"Optimal management for surgically Stage 1 serous cancer of the uterus","volume":"92","author":"Elit","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0115","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2003.08.027","article-title":"Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy","volume":"91","author":"Huh","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0120","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ygyno.2005.07.104","article-title":"The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC)","volume":"99","author":"Dietrich","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0125","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0046-8177(98)80012-9","article-title":"Loss of p53 function in uterine papillary serous carcinoma","volume":"29","author":"Kovalev","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0130","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/00000478-199812000-00003","article-title":"P53 immunostaining as a significant adjunct diagnostic method for uterine surface carcinoma: precursor of uterine papillary serous carcinoma","volume":"22","author":"Zheng","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0135","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/cncr.21308","article-title":"Amplification of c-erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma","volume":"104","author":"Santin","year":"2005","journal-title":"Cancer"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0140","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1200\/JCO.2004.11.154","article-title":"Her-2\/neu overexpression and amplification in uterine papillary serous carcinoma","volume":"22","author":"Slomovitz","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0145","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/ijgc-00009577-200609000-00027","article-title":"HER-2\/neu overexpression in uterine papillary serous cancers and its possible therapeutic implications","volume":"16","author":"Villella","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0150","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1200\/JCO.2005.04.144","article-title":"Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer","volume":"23","author":"Cragun","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200807000-00033_bb0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2005.11.032","article-title":"Pelvic lymph node count is an important prognostic variable for FIGO Stage I and II endometrial carcinoma with high-risk histology","volume":"102","author":"Lutman","year":"2006","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24035291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24035291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-00009577-200807000-00033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:22:27Z","timestamp":1753222947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24035291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":31,"aliases":["10.1111\/j.1525-1438.2007.01082.x"],"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S1048891X24035291"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-00009577-200807000-00033","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is adjuvant therapy necessary for Stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-00009577-200807000-00033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008, IGCS and ESGO","name":"copyright","label":"Copyright"}]}}